APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Over the Counter (OTC) Analgesics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Over the Counter (OTC) Analgesics Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchOver the Counter (OTC) Analgesics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Over the Counter (OTC) Analgesics Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Over the Counter (OTC) Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over the Counter (OTC) Analgesics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Over the Counter (OTC) Analgesics Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Over the Counter (OTC) Analgesics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over the Counter (OTC) Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Over the Counter (OTC) Analgesics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Over the Counter (OTC) Analgesics market include Takeda Pharmaceutical Company Limited., Sanofi SA, Johnson & Johnson, Novartis, Pfizer, Bayer AG, AstraZeneca, Sun Pharma and Reckitt Benckiser Group PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Over the Counter (OTC) Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over the Counter (OTC) Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over the Counter (OTC) Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Over the Counter (OTC) Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Over the Counter (OTC) Analgesics Segment by Company

Takeda Pharmaceutical Company Limited.

Sanofi SA

Johnson & Johnson

Novartis

Pfizer

Bayer AG

AstraZeneca

Sun Pharma

Reckitt Benckiser Group PLC

GlaxoSmithKline PLC

Boehringer Ingelheim International GmbH

Over the Counter (OTC) Analgesics Segment by Type

Tablet

Capsule

Other

Over the Counter (OTC) Analgesics Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Over the Counter (OTC) Analgesics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Over the Counter (OTC) Analgesics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Over the Counter (OTC) Analgesics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Over the Counter (OTC) Analgesics significant trends, drivers, influence factors in global and regions.

6. To analyze Over the Counter (OTC) Analgesics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over the Counter (OTC) Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over the Counter (OTC) Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over the Counter (OTC) Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Over the Counter (OTC) Analgesics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Over the Counter (OTC) Analgesics industry.

Chapter 3: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Over the Counter (OTC) Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Over the Counter (OTC) Analgesics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Over the Counter (OTC) Analgesics Industry Trends Table 2. Over the Counter (OTC) Analgesics Industry Drivers Table 3. Over the Counter (OTC) Analgesics Industry Opportunities and Challenges Table 4. Over the Counter (OTC) Analgesics Industry Restraints Table 5. Global Over the Counter (OTC) Analgesics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Over the Counter (OTC) Analgesics Revenue Share by Company (2021-2026) Table 7. Global Over the Counter (OTC) Analgesics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Over the Counter (OTC) Analgesics Sales Volume Share by Company (2021-2026) Table 9. Global Over the Counter (OTC) Analgesics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Over the Counter (OTC) Analgesics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Over the Counter (OTC) Analgesics Key Company Manufacturing Base & Headquarters Table 12. Global Over the Counter (OTC) Analgesics Company, Product Type & Application Table 13. Global Over the Counter (OTC) Analgesics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Over the Counter (OTC) Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Capsule Table 19. Significant Companies of Other Table 20. Global Over the Counter (OTC) Analgesics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Over the Counter (OTC) Analgesics Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Over the Counter (OTC) Analgesics Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Over the Counter (OTC) Analgesics Sales Volume Share by Type (2021-2026) Table 24. Global Over the Counter (OTC) Analgesics Sales Volume Share by Type (2027-2032) Table 25. Global Over the Counter (OTC) Analgesics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Over the Counter (OTC) Analgesics Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Over the Counter (OTC) Analgesics Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Over the Counter (OTC) Analgesics Sales Value Share by Type (2021-2026) Table 29. Global Over the Counter (OTC) Analgesics Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Online Pharmacies Table 32. Significant Companies of Hospital Pharmacies Table 33. Global Over the Counter (OTC) Analgesics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Over the Counter (OTC) Analgesics Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Over the Counter (OTC) Analgesics Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Over the Counter (OTC) Analgesics Sales Volume Share by Application (2021-2026) Table 37. Global Over the Counter (OTC) Analgesics Sales Volume Share by Application (2027-2032) Table 38. Global Over the Counter (OTC) Analgesics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Over the Counter (OTC) Analgesics Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Over the Counter (OTC) Analgesics Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Over the Counter (OTC) Analgesics Sales Value Share by Application (2021-2026) Table 42. Global Over the Counter (OTC) Analgesics Sales Value Share by Application (2027-2032) Table 43. Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Over the Counter (OTC) Analgesics Sales by Region (2021-2026) & (K Units) Table 45. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2021-2026) Table 46. Global Over the Counter (OTC) Analgesics Sales by Region (2027-2032) & (K Units) Table 47. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2027-2032) Table 48. Global Over the Counter (OTC) Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Over the Counter (OTC) Analgesics Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Over the Counter (OTC) Analgesics Sales Value Share by Region (2021-2026) Table 51. Global Over the Counter (OTC) Analgesics Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Over the Counter (OTC) Analgesics Sales Value Share by Region (2027-2032) Table 53. Global Over the Counter (OTC) Analgesics Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Over the Counter (OTC) Analgesics Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Over the Counter (OTC) Analgesics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Over the Counter (OTC) Analgesics Sales by Country (2021-2026) & (K Units) Table 58. Global Over the Counter (OTC) Analgesics Sales Market Share by Country (2021-2026) Table 59. Global Over the Counter (OTC) Analgesics Sales by Country (2027-2032) & (K Units) Table 60. Global Over the Counter (OTC) Analgesics Sales Market Share by Country (2027-2032) Table 61. Global Over the Counter (OTC) Analgesics Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Over the Counter (OTC) Analgesics Sales Value Market Share by Country (2021-2026) Table 63. Global Over the Counter (OTC) Analgesics Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Over the Counter (OTC) Analgesics Sales Value Market Share by Country (2027-2032) Table 65. Takeda Pharmaceutical Company Limited. Company Information Table 66. Takeda Pharmaceutical Company Limited. Business Overview Table 67. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio Table 69. Takeda Pharmaceutical Company Limited. Recent Development Table 70. Sanofi SA Company Information Table 71. Sanofi SA Business Overview Table 72. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio Table 74. Sanofi SA Recent Development Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Novartis Over the Counter (OTC) Analgesics Product Portfolio Table 84. Novartis Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Over the Counter (OTC) Analgesics Product Portfolio Table 89. Pfizer Recent Development Table 90. Bayer AG Company Information Table 91. Bayer AG Business Overview Table 92. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Bayer AG Over the Counter (OTC) Analgesics Product Portfolio Table 94. Bayer AG Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio Table 99. AstraZeneca Recent Development Table 100. Sun Pharma Company Information Table 101. Sun Pharma Business Overview Table 102. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio Table 104. Sun Pharma Recent Development Table 105. Reckitt Benckiser Group PLC Company Information Table 106. Reckitt Benckiser Group PLC Business Overview Table 107. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio Table 109. Reckitt Benckiser Group PLC Recent Development Table 110. GlaxoSmithKline PLC Company Information Table 111. GlaxoSmithKline PLC Business Overview Table 112. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio Table 114. GlaxoSmithKline PLC Recent Development Table 115. Boehringer Ingelheim International GmbH Company Information Table 116. Boehringer Ingelheim International GmbH Business Overview Table 117. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio Table 119. Boehringer Ingelheim International GmbH Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Over the Counter (OTC) Analgesics Distributors List Table 123. Over the Counter (OTC) Analgesics Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Over the Counter (OTC) Analgesics Product Image Figure 2. Global Over the Counter (OTC) Analgesics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over the Counter (OTC) Analgesics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Over the Counter (OTC) Analgesics Sales (2021-2032) & (K Units) Figure 5. Global Over the Counter (OTC) Analgesics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Over the Counter (OTC) Analgesics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Capsule Image Figure 11. Other Image Figure 12. Global Over the Counter (OTC) Analgesics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Over the Counter (OTC) Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Over the Counter (OTC) Analgesics Sales Volume Share by Type (2021-2032) Figure 15. Global Over the Counter (OTC) Analgesics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Over the Counter (OTC) Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Over the Counter (OTC) Analgesics Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Online Pharmacies Image Figure 20. Hospital Pharmacies Image Figure 21. Global Over the Counter (OTC) Analgesics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Over the Counter (OTC) Analgesics Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Over the Counter (OTC) Analgesics Sales Volume Share by Application (2021-2032) Figure 24. Global Over the Counter (OTC) Analgesics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Over the Counter (OTC) Analgesics Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Over the Counter (OTC) Analgesics Sales Value Share by Application (2021-2032) Figure 27. Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Over the Counter (OTC) Analgesics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Over the Counter (OTC) Analgesics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Over the Counter (OTC) Analgesics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Over the Counter (OTC) Analgesics Sales Value (2021-2032) & (US$ Million) Figure 32. North America Over the Counter (OTC) Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Over the Counter (OTC) Analgesics Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Over the Counter (OTC) Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Over the Counter (OTC) Analgesics Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Over the Counter (OTC) Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Over the Counter (OTC) Analgesics Sales Value (2021-2032) & (US$ Million) Figure 38. South America Over the Counter (OTC) Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Over the Counter (OTC) Analgesics Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Over the Counter (OTC) Analgesics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Over the Counter (OTC) Analgesics Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Over the Counter (OTC) Analgesics Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Takeda Pharmaceutical Company Limited.
  • Sanofi SA
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Bayer AG
  • AstraZeneca
  • Sun Pharma
  • Reckitt Benckiser Group PLC
  • GlaxoSmithKline PLC
  • Boehringer Ingelheim International GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Over the Counter (OTC) Analgesics Sales Value (2021-2032)
  4. 1.2.2 Global Over the Counter (OTC) Analgesics Sales Volume (2021-2032)
  5. 1.2.3 Global Over the Counter (OTC) Analgesics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Over the Counter (OTC) Analgesics Market Dynamics
  1. 2.1 Over the Counter (OTC) Analgesics Industry Trends
  2. 2.2 Over the Counter (OTC) Analgesics Industry Drivers
  3. 2.3 Over the Counter (OTC) Analgesics Industry Opportunities and Challenges
  4. 2.4 Over the Counter (OTC) Analgesics Industry Restraints
3 Over the Counter (OTC) Analgesics Market by Company
  1. 3.1 Global Over the Counter (OTC) Analgesics Company Revenue Ranking in 2025
  2. 3.2 Global Over the Counter (OTC) Analgesics Revenue by Company (2021-2026)
  3. 3.3 Global Over the Counter (OTC) Analgesics Sales Volume by Company (2021-2026)
  4. 3.4 Global Over the Counter (OTC) Analgesics Average Price by Company (2021-2026)
  5. 3.5 Global Over the Counter (OTC) Analgesics Company Ranking (2024-2026)
  6. 3.6 Global Over the Counter (OTC) Analgesics Company Manufacturing Base and Headquarters
  7. 3.7 Global Over the Counter (OTC) Analgesics Company Product Type and Application
  8. 3.8 Global Over the Counter (OTC) Analgesics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Over the Counter (OTC) Analgesics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Over the Counter (OTC) Analgesics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Over the Counter (OTC) Analgesics Market by Type
  1. 4.1 Over the Counter (OTC) Analgesics Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Capsule
  4. 4.1.3 Other
  5. 4.2 Global Over the Counter (OTC) Analgesics Sales Volume by Type
  6. 4.2.1 Global Over the Counter (OTC) Analgesics Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Over the Counter (OTC) Analgesics Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Over the Counter (OTC) Analgesics Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Over the Counter (OTC) Analgesics Sales Value by Type
  10. 4.3.1 Global Over the Counter (OTC) Analgesics Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Over the Counter (OTC) Analgesics Sales Value by Type (2021-2032)
  12. 4.3.3 Global Over the Counter (OTC) Analgesics Sales Value Share by Type (2021-2032)
5 Over the Counter (OTC) Analgesics Market by Application
  1. 5.1 Over the Counter (OTC) Analgesics Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.2 Global Over the Counter (OTC) Analgesics Sales Volume by Application
  6. 5.2.1 Global Over the Counter (OTC) Analgesics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Over the Counter (OTC) Analgesics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Over the Counter (OTC) Analgesics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Over the Counter (OTC) Analgesics Sales Value by Application
  10. 5.3.1 Global Over the Counter (OTC) Analgesics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Over the Counter (OTC) Analgesics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Over the Counter (OTC) Analgesics Sales Value Share by Application (2021-2032)
6 Over the Counter (OTC) Analgesics Regional Sales and Value Analysis
  1. 6.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Over the Counter (OTC) Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2021-2026
  4. 6.2.2 Global Over the Counter (OTC) Analgesics Sales by Region (2027-2032)
  5. 6.3 Global Over the Counter (OTC) Analgesics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Over the Counter (OTC) Analgesics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Over the Counter (OTC) Analgesics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Over the Counter (OTC) Analgesics Sales Value by Region (2027-2032)
  9. 6.5 Global Over the Counter (OTC) Analgesics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Over the Counter (OTC) Analgesics Sales Value (2021-2032)
  12. 6.6.2 North America Over the Counter (OTC) Analgesics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Over the Counter (OTC) Analgesics Sales Value (2021-2032)
  15. 6.7.2 Europe Over the Counter (OTC) Analgesics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Over the Counter (OTC) Analgesics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Over the Counter (OTC) Analgesics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Over the Counter (OTC) Analgesics Sales Value (2021-2032)
  21. 6.9.2 South America Over the Counter (OTC) Analgesics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Over the Counter (OTC) Analgesics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Over the Counter (OTC) Analgesics Sales Value Share by Country, 2025 VS 2032
7 Over the Counter (OTC) Analgesics Country-level Sales and Value Analysis
  1. 7.1 Global Over the Counter (OTC) Analgesics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Over the Counter (OTC) Analgesics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Over the Counter (OTC) Analgesics Sales by Country (2021-2032)
  4. 7.3.1 Global Over the Counter (OTC) Analgesics Sales by Country (2021-2026)
  5. 7.3.2 Global Over the Counter (OTC) Analgesics Sales by Country (2027-2032)
  6. 7.4 Global Over the Counter (OTC) Analgesics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Over the Counter (OTC) Analgesics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Over the Counter (OTC) Analgesics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Over the Counter (OTC) Analgesics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Over the Counter (OTC) Analgesics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Over the Counter (OTC) Analgesics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical Company Limited.
  2. 8.1.1 Takeda Pharmaceutical Company Limited. Company Information
  3. 8.1.2 Takeda Pharmaceutical Company Limited. Business Overview
  4. 8.1.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Company Limited. Recent Developments
  7. 8.2 Sanofi SA
  8. 8.2.1 Sanofi SA Company Information
  9. 8.2.2 Sanofi SA Business Overview
  10. 8.2.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio
  12. 8.2.5 Sanofi SA Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Bayer AG
  32. 8.6.1 Bayer AG Company Information
  33. 8.6.2 Bayer AG Business Overview
  34. 8.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio
  36. 8.6.5 Bayer AG Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Sun Pharma
  44. 8.8.1 Sun Pharma Company Information
  45. 8.8.2 Sun Pharma Business Overview
  46. 8.8.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio
  48. 8.8.5 Sun Pharma Recent Developments
  49. 8.9 Reckitt Benckiser Group PLC
  50. 8.9.1 Reckitt Benckiser Group PLC Company Information
  51. 8.9.2 Reckitt Benckiser Group PLC Business Overview
  52. 8.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio
  54. 8.9.5 Reckitt Benckiser Group PLC Recent Developments
  55. 8.10 GlaxoSmithKline PLC
  56. 8.10.1 GlaxoSmithKline PLC Company Information
  57. 8.10.2 GlaxoSmithKline PLC Business Overview
  58. 8.10.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio
  60. 8.10.5 GlaxoSmithKline PLC Recent Developments
  61. 8.11 Boehringer Ingelheim International GmbH
  62. 8.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 8.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 8.11.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio
  66. 8.11.5 Boehringer Ingelheim International GmbH Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Over the Counter (OTC) Analgesics Value Chain Analysis
  2. 9.1.1 Over the Counter (OTC) Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Over the Counter (OTC) Analgesics Sales Mode & Process
  6. 9.2 Over the Counter (OTC) Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Over the Counter (OTC) Analgesics Distributors
  9. 9.2.3 Over the Counter (OTC) Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst